Vendor, Houston, TX
Gene by Gene, Limited
UEI SG1RJE5JG1K6, CAGE 6Z3B5
2 awards and -$20,882 obligated between July 5, 2024 and July 31, 2025, 0% under full and open competition, against 3.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | -$882 |
| Food and Drug Administration | -$20,000 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$882 |
| Research and Development in the Social Sciences and HumanitiesNAICS 541720 | -$20,000 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 2 |
| Purchase Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93020P01407Purchase Order, July 31, 2025, Competed Under SAP, 3 offers | National Institutes of Health NiaidNational Institutes of Health | SNP ArraysNAICS 541714, PSC Q301 | -$882 |
| 75F40122P00530Purchase Order, July 5, 2024, Competed Under SAP, 3 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Provide Sequencing Services on Purified Human Genomic Dna Samples.NAICS 541720, PSC AN21 | -$20,000 |
- Places of performance
- Texas
- Product and service codes
- Q301 Reference Laboratory TestingAN21 Health R&D Services; Health Research And Training; Basic Research
- Transactions
- 2 across 2 awards